bottom line, the company needs money to survive. you seem to understand the realistic view behind that statement. while some here claim that the company is undervalued at these prices, and to get ready for a spike upwards, we know its just pumping b.s. the company could be considered undervalued if it had the necessary funds to support its ongoing trials, but with little money left to carry its dreams forward, why would the price be doing anything else than the latest declining trend? the market knows the companies situation.
if the company does not partner or better yet get sold, Rachel m. price target might not look so dumb after all.
